ONTX stock forecast
Our latest prediction for Onconova Therapeutics, Inc.'s stock price was made on the Sept. 24, 2019 when the stock price was at 1.16$.
In the short term (2weeks), ONTX's stock price should underperform the market by -0.42%. During that period the price should oscillate between -13.46% and +27.42%.
In the medium term (3months), ONTX's stock price should outperform the market by 10.70%. During that period the price should oscillate between -27.49% and +68.74%.Get email alerts
About Onconova Therapeutics, Inc.
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -3.12$ per share.
The book value per share is 0.18$
Three months stock forecastSept. 24, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|